Rikke Sørensen

Medicin og biovidenskab

1. Myocardial Infarction 100%
2. Percutaneous Coronary Intervention 81%
3. ST Elevation Myocardial Infarction 78%
4. Clopidogrel 59%
5. Chronic Obstructive Pulmonary Disease 58%
6. Acute Coronary Syndrome 56%
7. Cohort Studies 51%
8. Stents 50%
9. Atrial Fibrillation 49%
10. Mortality 48%
11. Drug-Eluting Stents 42%
12. Hemorrhage 42%
13. Metals 34%
14. Registries 32%
15. Hospitalization 29%
16. Anticoagulants 25%
17. Dabigatran 25%
18. Vitamin K 25%
19. Heart Failure 23%
20. Therapeutics 23%
21. Aspirin 20%
22. Denmark 19%
23. Anti-Inflammatory Agents 19%
24. Pharmaceutical Preparations 19%
25. Ischemic Postconditioning 19%
26. Coronary Angiography 17%
27. Coronary Artery Bypass 17%
28. Warfarin 16%
29. Coronary Vessels 15%
30. Incidence 15%
31. Safety 15%
32. Thrombectomy 15%
33. Population 15%
34. Confidence Intervals 15%
35. Rivaroxaban 14%
36. Proportional Hazards Models 14%
37. Hormone Replacement Therapy 14%
38. Stroke 14%
39. apixaban 14%
40. Coronary Artery Disease 13%
41. Propensity Score 13%
42. Aortic Valve Stenosis 13%
43. Ticagrelor 12%
44. Duration of Therapy 12%
45. Pseudomonas aeruginosa 11%
46. Thrombosis 11%
47. Drug Therapy 11%
48. Cause of Death 11%
49. Adrenal Cortex Hormones 11%
50. Pneumonia 10%